U.S. Markets closed

What Does Colony Bankcorp Inc’s (NASDAQ:CBAN) PE Ratio Tell You?

Michael Crabtree

This article is intended for those of you who are at the beginning of your investing journey and want to start learning about core concepts of fundamental analysis on practical examples from today’s market.

Colony Bankcorp Inc (NASDAQ:CBAN) is trading with a trailing P/E of 15.4x, which is lower than the industry average of 17.9x. While this makes CBAN appear like a great stock to buy, you might change your mind after I explain the assumptions behind the P/E ratio. In this article, I will explain what the P/E ratio is as well as what you should look out for when using it.

View our latest analysis for Colony Bankcorp

What you need to know about the P/E ratio

NasdaqGM:CBAN PE PEG Gauge September 12th 18

The P/E ratio is a popular ratio used in relative valuation since earnings power is a key driver of investment value. By comparing a stock’s price per share to its earnings per share, we are able to see how much investors are paying for each dollar of the company’s earnings.

P/E Calculation for CBAN

Price-Earnings Ratio = Price per share ÷ Earnings per share

CBAN Price-Earnings Ratio = $17.25 ÷ $1.121 = 15.4x

The P/E ratio itself doesn’t tell you a lot; however, it becomes very insightful when you compare it with other similar companies. Our goal is to compare the stock’s P/E ratio to the average of companies that have similar attributes to CBAN, such as company lifetime and products sold. A quick method of creating a peer group is to use companies in the same industry, which is what I will do. CBAN’s P/E of 15.4 is lower than its industry peers (17.9), which implies that each dollar of CBAN’s earnings is being undervalued by investors. This multiple is a median of profitable companies of 25 Banks companies in US including Great Basin Financial, Mercantil Servicios Financieros C.A and CIB Marine Bancshares. You can think of it like this: the market is suggesting that CBAN is a weaker business than the average comparable company.

A few caveats

However, there are two important assumptions you should be aware of. The first is that our “similar companies” are actually similar to CBAN, or else the difference in P/E might be a result of other factors. For example, if you compared lower risk firms with CBAN, then investors would naturally value it at a lower price since it is a riskier investment. The second assumption that must hold true is that the stocks we are comparing CBAN to are fairly valued by the market. If this does not hold, there is a possibility that CBAN’s P/E is lower because our peer group is overvalued by the market.

What this means for you:

If your personal research into the stock confirms what the P/E ratio is telling you, it might be a good time to add more of CBAN to your portfolio. But keep in mind that the usefulness of relative valuation depends on whether you are comfortable with making the assumptions I mentioned above. Remember that basing your investment decision off one metric alone is certainly not sufficient. There are many things I have not taken into account in this article and the PE ratio is very one-dimensional. If you have not done so already, I highly recommend you to complete your research by taking a look at the following:

  1. Future Outlook: What are well-informed industry analysts predicting for CBAN’s future growth? Take a look at our free research report of analyst consensus for CBAN’s outlook.
  2. Past Track Record: Has CBAN been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of CBAN’s historicals for more clarity.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.